BRB Award
In Vascular Biology & Thrombosis Research
The Bernd R. Binder Publication Prize was established in Memory of the founder of Technoclone Prof. Dr. Bernd R. Binder (1945-2010) to promote young scientists who have shown an outstanding contribution to the field of Vascular Biology and Thrombosis Research.
This prize underlines Technoclone's tradition in fostering and supporting innovative research in academia an outstanding contribution to the field of Vascular Biology and Thrombosis Research.
After 10 years being part of the Joint Meeting on Vascular Biology, Inflammation and Thrombosis, we are happy to announce that from 2023 on the BRB Publication Prize will be part of the European Congress on Thrombosis and Haemostasis (ECTH) https://www.ecth.org. The ECTH brings together researchers, scientists, clinicians and other healthcare professionals at the premier scientific congress in Europe around thrombosis and bleeding. It offers a comprehensive scientific and clinical education across a broad set of current and soon-to-be released studies, new findings, treatments or products.
About the BRB Publication Prize
One award of € 2,500.- to the first author of an excellent original article in the areas of Vascular Biology and Thrombosis Research published in an international peer-reviewed journal.
Applicants are first author of a publication from an independent research institution (university, public research institute, etc.) in the area of Vascular Biology and/or Thrombosis Research.
The paper must be a journal article published (in print or online) in an international peer-reviewed journal in the corresponding year.
The prize will be awarded following the recommendation of a selected prize award committee.
In 2025, the publication prizes will be awarded for 2 years: apply by June 30, 2025 for the publication prize for the year 2023 and 2024. Download application form
The publication prize for the year 2023 & 2024 will be awarded to the winners at the opening ceremony of the ECTH on October 22, 2025 in Prague, Czech Republic.
The publication prize also includes free registration at the ECTH the European Congress of Thrombosis & Haemostasis https://www.ecth.org from October 22-24, 2025 in Prague, Czech Republic and the refund of the associated travel costs.
For any further questions please contact awards@technoclone.com
Previous Winners of the BRB Publication Prize
| Year | Name | Article |
| 2022 |
Dr. Sarajo Mohanta |
Neuroimmune cardiovascular interfaces control atherosclerosis |
|
2021 |
Dimitrios Tsiantoulas |
APRIL limits atherosclerosis by binding to heparan sulfate proteoglycans |
| 2019/2020 |
Anja Nitzsche |
Endothelial S1P1 Signaling Counteracts Infarct Expansion in Ischemic Stroke |
| 2018 | Lynda Zeboudj |
Selective EGF-Receptor Inhibition in CD4þ T Cells Induces Anergy and Limits Atherosclerosis |
| 2017 |
|
Host DNases prevent vascular |
| 2016 |
Emiel van der Vorst |
High-Density Lipoproteins Exert Pro- |
| 2015 |
Katrin F. Nickel |
The polyphosphate-factor XII pathway |
| 2014 |
Andrew Sage |
MHC Class II-Restricted Antigen |
| 2013 |
Martin Schmitt |
Endothelial JAM-A guides monocytes into |
|
2012
|
*Nikolina Papac-Milicevic *lecture only |
The interferon stimulated gene 12 inactivates vasculoprotective functions of NR4A nuclear receptors. Circulation Research 2012; 110 (8):e50-63 |